Brown-Forman stays steady through cost cutting but faces tough 2025. Read why BF.A stock might struggle despite its flagship ...

Neoadjuvant semaglutide showed no benefit in weight loss, diabetes remission or safety in a cohort of patients who underwent ...

Originally developed to treat Type 2 diabetes, glucagon-like peptide 1 (GLP-1s) are now being studied to explore their ...

The rise of GLP-1 drugs like Ozempic are changing consumer food waste patterns both at home and in restaurant settings.

Hims & Hers is expanding access to Eli Lilly's branded weight loss drug Zepbound and diabetes drug Mounjaro as well as ...

While most guidelines require 6 months of behavioral interventions before prescribing weight-loss drugs, new research shows ...

Researchers say payers should take the added costs of drugs prescribed to deal with GLP-1 side effects into account when ...

The effect of glucagon-like peptide 1 receptor agonists on patients with joint infections was a popular topic at the American ...

Perez Hilton has struggled with weight management for decades. Now, he’s spreading the word about the benefits of GLP-1 drugs ...

The FDA's new rule restricting the sale of compounded semaglutide could make it more difficult for some people to obtain ...

For a variety of reasons, Globe Food contributor Kara Baskin took the leap and started Zepbound. But first she worried: "What ...